News
02-04-2014, 01:40 AM
Sanford Heart Hospital has started a clinical trial to study a dissolving device in patients with coronary artery disease. The ABSORB III clinical trial will investigate the safety and effectiveness of the Absorb Bioresorbable Vascular Scaffold (BVS) device, manufactured by global health care company Abbott.
More... (http://www.news-medical.net/news/20140204/Sanford-Hospital-starts-clinical-trial-to-study-dissolving-device-in-patients-with-CAD.aspx)
More... (http://www.news-medical.net/news/20140204/Sanford-Hospital-starts-clinical-trial-to-study-dissolving-device-in-patients-with-CAD.aspx)